| ID | Sequence | Length | GC content |
|---|---|---|---|
| AGGAAAGGUGGUUGGCUUACGGCACAGUAGAGAGCUUCCAGGGCUGGCU… | 2193 nt | 0.4774 | |
| AGGAAAGGUGGUUGGCUUACGGCACAGUAGAGAGCUUCCAGGGCUGGCU… | 1971 nt | 0.4825 | |
| AGGAAAGGUGGUUGGCUUACGGCACAGUAGAGAGCUUCCAGGGCUGGCU… | 2349 nt | 0.4717 |
This gene encodes a member of the class B seven-span transmembrane (TM7) receptor family expressed predominantly by cells of the immune system. Family members are characterized by an extended extracellular region with a variable number of N-terminal epidermal growth factor (EGF)-like domains coupled to a TM7 domain via a mucin-like spacer domain. This gene is closely linked to the gene encoding egf-like molecule containing mucin-like hormone receptor 2 on chromosome 19. This protein may play a role in myeloid-myeloid interactions during immune and inflammatory responses. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2014]
A study in humans analyzing leukocyte gene expression profiles from severe burn patients identified the ADGRE3 as a top sustained increasing gene (SIG) with expression rising from the healthy state through the late recovery phase (>400 hours post-injury), classifying it as a biomarker for burn recovery [Xu et al. DOI:10.1159/000493451]. A separate human study on sepsis, utilizing transcriptome profiling of peripheral blood mononuclear cells, mentioned the ADGRE3 as a predictor of septic patients identified in previous research, though it was not directly studied in that experimental cohort [Wu et al. DOI:10.7150/ijms.46910].